Compare MIAX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIAX | HAE |
|---|---|---|
| Founded | 2007 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2025 | 1996 |
| Metric | MIAX | HAE |
|---|---|---|
| Price | $42.59 | $108.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $47.00 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.2M | 866.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.95 | 0.72 |
| Revenue | ★ $1,364,073,000.00 | $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.20 | $5.23 |
| P/E Ratio | ★ $21.19 | $150.31 |
| Revenue Growth | ★ 19.65 | N/A |
| 52 Week Low | $32.20 | $47.32 |
| 52 Week High | $57.14 | $109.56 |
| Indicator | MIAX | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 84.95 |
| Support Level | $41.23 | $79.52 |
| Resistance Level | $44.26 | N/A |
| Average True Range (ATR) | 2.05 | 3.26 |
| MACD | -0.41 | 2.14 |
| Stochastic Oscillator | 44.82 | 99.44 |
Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.